ITMI20002019A0 - Metodo per il trattemento dei disturbi metabolici, in particolare diabete oppure una malattia oppure una condizione associate con il diabete - Google Patents

Metodo per il trattemento dei disturbi metabolici, in particolare diabete oppure una malattia oppure una condizione associate con il diabete

Info

Publication number
ITMI20002019A0
ITMI20002019A0 IT2000MI002019A ITMI20002019A ITMI20002019A0 IT MI20002019 A0 ITMI20002019 A0 IT MI20002019A0 IT 2000MI002019 A IT2000MI002019 A IT 2000MI002019A IT MI20002019 A ITMI20002019 A IT MI20002019A IT MI20002019 A0 ITMI20002019 A0 IT MI20002019A0
Authority
IT
Italy
Prior art keywords
diabetes
disease
treatment
condition associated
metabolic disorders
Prior art date
Application number
IT2000MI002019A
Other languages
English (en)
Inventor
Marjorie Regan Gatlin
Michele Pongowski
Richard Owen Mannion
Anees Abdulquadar Karnachi
Christiane Guitard
Allison Malcolm
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ITMI20002019A0 publication Critical patent/ITMI20002019A0/it
Publication of ITMI20002019A1 publication Critical patent/ITMI20002019A1/it

Links

IT2000MI002019A 1999-09-17 2000-09-15 Metodo per il trattemento dei disturbi metabolici, in particolare diabete oppure una malattia oppure una condizione associate con il diabete ITMI20002019A1 (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39836499A 1999-09-17 1999-09-17
US54548000A 2000-04-07 2000-04-07

Publications (2)

Publication Number Publication Date
ITMI20002019A0 true ITMI20002019A0 (it) 2000-09-15
ITMI20002019A1 ITMI20002019A1 (it) 2002-03-15

Family

ID=27016226

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI002019A ITMI20002019A1 (it) 1999-09-17 2000-09-15 Metodo per il trattemento dei disturbi metabolici, in particolare diabete oppure una malattia oppure una condizione associate con il diabete

Country Status (2)

Country Link
IT (1) ITMI20002019A1 (it)
RU (1) RU2280447C2 (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2373187C2 (ru) * 2003-06-24 2009-11-20 Ф.Хоффманн-Ля Рош Аг Биарилоксиметилареновые карбоновые кислоты
WO2009005483A1 (en) * 2007-07-02 2009-01-08 Mayank Jain Method for treating metabolic syndrome x
RU2339375C1 (ru) * 2007-07-09 2008-11-27 Илья Николаевич Медведев Способ коррекции вазопатии при метаболическом синдроме
RU2345765C1 (ru) * 2007-07-09 2009-02-10 Илья Николаевич Медведев Способ коррекции гиперфибриногенемии при метаболическом синдроме
RU2345766C1 (ru) * 2007-07-09 2009-02-10 Илья Николаевич Медведев Способ нормализации содержания липидов в мембранах тромбоцитов при метаболическом синдроме
RU2344818C1 (ru) * 2007-07-09 2009-01-27 Илья Николаевич Медведев СПОСОБ НОРМАЛИЗАЦИИ УРОВНЯ α2-АНТИПЛАЗМИНА ПРИ МЕТАБОЛИЧЕСКОМ СИНДРОМЕ
AR067557A1 (es) 2007-07-19 2009-10-14 Takeda Pharmaceutical Preparacion solida y metodo de preparacion
RU2423096C2 (ru) * 2009-05-18 2011-07-10 Илья Николаевич Медведев Способ быстрой оптимизации содержания липидов в мембранах тромбоцитов у больных артериальной гипертонией с нарушением толерантности к глюкозе
RU2408371C1 (ru) * 2009-10-12 2011-01-10 Илья Николаевич Медведев Способ снижения спонтанной агрегации эритроцитов при артериальной гипертонии с нарушением толерантности к глюкозе
RU2414217C1 (ru) * 2009-10-15 2011-03-20 Илья Николаевич Медведев Способ снижения спонтанной агрегации эритроцитов при артериальной гипертонии с метаболическим синдромом
RU2442580C2 (ru) * 2010-03-10 2012-02-20 Илья Николаевич Медведев Способ нормализации агрегации эритроцитов при артериальной гипертонии с нарушением толерантности к глюкозе
RU2451506C1 (ru) 2011-06-02 2012-05-27 Сергей Юрьевич Лешков Комбинация для лечения сахарного диабета и его осложнений
GB2492559B (en) * 2011-07-05 2018-07-25 Clasado Inc Composition and method for preventing or reducing the risk of developing a syndrome
US20150118215A1 (en) * 2012-03-30 2015-04-30 The General Hospital Corporation Methods of Inhibiting Cell Proliferation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
US5463116A (en) * 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
ATE201139T1 (de) * 1997-06-13 2001-06-15 Novo Nordisk As Neue dosierung für diabetes type 2

Also Published As

Publication number Publication date
RU2280447C2 (ru) 2006-07-27
ITMI20002019A1 (it) 2002-03-15

Similar Documents

Publication Publication Date Title
NO20021197D0 (no) Fremgangsmåte til behandling av stoffskiftesykdommer, spesielt diabetes, eller en sykdom eller tilstand forbundet meddiabetes
ITMI20002019A0 (it) Metodo per il trattemento dei disturbi metabolici, in particolare diabete oppure una malattia oppure una condizione associate con il diabete
AU2002327430A8 (en) Methods for treating diabetes and other blood sugar disorders
PT1224297E (pt) Secretase da doença de alzheimer, seus substratos app e suas utilizações
AU2001262943A1 (en) Methods for drug discovery, disease treatment, and diagnosis using metabolomics
BR9712808B1 (pt) indol-3-glioxilamidas n-substituìdas, bem como aplicação, medicamento e processo para a preparação das mesmas.
ZA200107989B (en) 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof.
BR0017050B1 (pt) oxazolidinonas substituÍdas, processo para sua produÇço, uso das mesmas e processo para impedir a coagulaÇço de sangue in vitro.
FI20000863L (fi) Uusi hoitomenetelmä
ZA200202521B (en) 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preprations containing said compounds.
IT1319201B1 (it) Farmaci per il diabete.
AU2002350172A1 (en) Substituted heterocyclic carboxamides with antithrombotic activity
EP1036844A4 (en) Test methods, test reagent and remedies for diseases caused by changes in the LKB1 gene
WO2001026651A3 (en) Selective estrogen receptor modulators in the treatment or reduction of the risk of acquiring hypertension, cardiovascular diseases, and insulin resistance
ATE251170T1 (de) Titanverbindungen, deren herstellung und verwendung
AU2003252182A1 (en) Therapeutic treatment for the metabolic syndrome and type 2 diabetes
AU2003253036A1 (en) Process for the preparation of optically active 3-n-methylamino-1-(2-thienyl)-1-propanol
ITTO20000745A0 (it) Nuovi acidi naftilsolfonici e composti ad essi correlati utli come agonisti dell'assorbimento del glucosio.
MXPA01003761A (es) Agente para tratar oftalmopatia.
ZA200309946B (en) Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes.
IT1320053B1 (it) Telaio scocca per motociclo.
PT1556380E (pt) Derivados de piridoindolona substituidos na posicao 3 por um grupo heterociclico, a sua preparacao e a sua aplicacao em terapeutica.
GB0021055D0 (en) Method of treating metabolic disorders,espicially diabetes,or a disease or condition associated with diabetes
WO2003062469A3 (en) Gene matn3 or matrilin-3 linked to osteoarthritis treatment
IL182125A0 (en) Optically active 4,4-di-substituted oxazolidine derivatives and processes for the preparation thereof